From GlobeNewswire:

ALK (ALKB:DC / OMX: ALK B / AKBLF) will release the 2023 annual report on Thursday, February 8, 2024, in the afternoon. They will also hold a teleconference at 4:00 PM (CET) on the same day to present the results and expectations. The meeting will be webcasted at https://ir.alk.net, with the presentation available shortly before the start. Registration for the conference is available at https://dpregister.com/sreg/10185513/fb5a5565cd, with instructions provided on the page. ALK is a global pharmaceutical company specializing in allergy and allergic asthma, with around 2,900 employees worldwide and listed on Nasdaq Copenhagen.



Read more: Dato for offentliggørelse af årsrapport for 2023 for ALK og